LTPA2019508I1 - Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui - Google Patents

Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Info

Publication number
LTPA2019508I1
LTPA2019508I1 LTPA2019508C LTPA2019508C LTPA2019508I1 LT PA2019508 I1 LTPA2019508 I1 LT PA2019508I1 LT PA2019508 C LTPA2019508 C LT PA2019508C LT PA2019508 C LTPA2019508 C LT PA2019508C LT PA2019508 I1 LTPA2019508 I1 LT PA2019508I1
Authority
LT
Lithuania
Prior art keywords
soluble
hard
water
active substances
pharmaceutically active
Prior art date
Application number
LTPA2019508C
Other languages
English (en)
Original Assignee
Ardenia Investments Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTPA2019508(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardenia Investments Ltd. filed Critical Ardenia Investments Ltd.
Publication of LTPA2019508I1 publication Critical patent/LTPA2019508I1/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTPA2019508C 2007-12-19 2019-04-25 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui LTPA2019508I1 (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number Publication Date
LTPA2019508I1 true LTPA2019508I1 (lt) 2019-05-10

Family

ID=40795732

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP08861526.5T LT2231189T (lt) 2007-12-19 2008-12-18 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
LTPA2019508C LTPA2019508I1 (lt) 2007-12-19 2019-04-25 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP08861526.5T LT2231189T (lt) 2007-12-19 2008-12-18 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Country Status (27)

Country Link
US (4) US8999382B2 (lt)
EP (1) EP2231189B1 (lt)
JP (1) JP5466172B2 (lt)
KR (1) KR101572703B1 (lt)
CN (1) CN101951956B (lt)
AU (1) AU2008339099B2 (lt)
BR (1) BRPI0821740B1 (lt)
CA (1) CA2709266C (lt)
CY (2) CY1119805T1 (lt)
DK (1) DK2231189T3 (lt)
EA (1) EA015247B1 (lt)
ES (1) ES2650242T3 (lt)
FR (1) FR19C1030I1 (lt)
HR (1) HRP20171796T1 (lt)
HU (1) HUE034684T2 (lt)
LT (2) LT2231189T (lt)
LU (1) LUC00117I2 (lt)
MX (1) MX2010006914A (lt)
MY (2) MY157186A (lt)
NL (1) NL300987I9 (lt)
NO (2) NO2231189T3 (lt)
NZ (1) NZ586859A (lt)
PL (1) PL2231189T3 (lt)
PT (1) PT2231189T (lt)
SI (1) SI2231189T1 (lt)
WO (2) WO2009078754A1 (lt)
ZA (1) ZA201004685B (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
EP2421561A2 (en) * 2009-04-21 2012-02-29 Selecta Biosciences, Inc. Immunonanotherapeutics providing a th1-biased response
EP2575773A4 (en) 2010-05-26 2014-06-25 Selecta Biosciences Inc SYNTHETIC NANOTRÄGERKOMBINATIONSIMPFSTOFFE
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112321465B (zh) * 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
CN100360502C (zh) * 2002-07-23 2008-01-09 阿登尼亚投资有限公司 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
US20050196343A1 (en) 2004-02-27 2005-09-08 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2007001356A2 (en) * 2004-09-10 2007-01-04 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
KR101643416B1 (ko) * 2005-08-31 2016-07-27 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

Also Published As

Publication number Publication date
PL2231189T3 (pl) 2018-03-30
WO2009078802A1 (en) 2009-06-25
DK2231189T3 (en) 2017-12-11
BRPI0821740A2 (pt) 2020-02-27
HRP20171796T1 (hr) 2018-01-26
MX2010006914A (es) 2010-11-10
EA015247B1 (ru) 2011-06-30
CA2709266A1 (en) 2009-06-25
NO2231189T3 (lt) 2018-02-03
SI2231189T1 (en) 2018-03-30
MY157186A (en) 2016-05-13
US8999382B2 (en) 2015-04-07
JP5466172B2 (ja) 2014-04-09
CN101951956B (zh) 2012-10-17
ZA201004685B (en) 2011-03-30
AU2008339099B2 (en) 2015-08-13
US9993438B2 (en) 2018-06-12
EP2231189B1 (en) 2017-09-06
BRPI0821740B1 (pt) 2021-05-18
NL300987I9 (nl) 2019-05-16
KR20100094575A (ko) 2010-08-26
LT2231189T (lt) 2017-12-27
US20150164819A1 (en) 2015-06-18
MY157187A (en) 2016-05-13
FR19C1030I1 (fr) 2019-06-21
CY1119805T1 (el) 2018-06-27
CY2019021I2 (el) 2019-11-27
NO2019023I1 (no) 2019-05-08
EP2231189A1 (en) 2010-09-29
CA2709266C (en) 2017-09-26
CY2019021I1 (el) 2019-11-27
WO2009078754A1 (en) 2009-06-25
ES2650242T3 (es) 2018-01-17
NZ586859A (en) 2012-06-29
PT2231189T (pt) 2017-12-12
LUC00117I2 (lt) 2024-05-22
EA200802350A3 (ru) 2009-10-30
KR101572703B1 (ko) 2015-11-27
AU2008339099A1 (en) 2009-06-25
CN101951956A (zh) 2011-01-19
USRE49742E1 (en) 2023-12-05
NL300987I2 (lt) 2019-05-09
HUE034684T2 (en) 2018-02-28
EA200802350A2 (ru) 2009-06-30
JP2011507838A (ja) 2011-03-10
USRE49741E1 (en) 2023-12-05
US20110014281A1 (en) 2011-01-20
EP2231189A4 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
BRPI0917030A2 (pt) sistema de liberação de fármaco contendo progestina
BRPI0913214A2 (pt) sistema de fornecimento de drogas transdérmico estabilizado
BRPI0716196A2 (pt) Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
PL1834635T3 (pl) Stabilne układy nanokapsułek do podawania cząsteczek aktywnych
BRPI1014139A2 (pt) sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
DK2185220T3 (da) Anordning til lægemiddelfremføring
BRPI0818129A2 (pt) Sistema de transporte e administração de medicamento seguro
DK2010190T3 (da) Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer
DK2308514T3 (da) Konjugater til målrettet lægemiddeltransport gennem blod-hjerne barrieren
BRPI0819245A2 (pt) sistema de distribuição transdérmica
DK2343071T3 (da) Farmaceutiske doseringsformer
IL193019A0 (en) Drug delivery systems containing weakly basic drugs and organic acids and methods for the preparation thereof
ZA201002014B (en) Drug delivery system
IL242028A0 (en) A system for dispensing doses of medicine operated by means of a micro-pump
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
DK2231254T3 (da) Implanterbar lægemiddelafgivelsesindretning
BR112012002981A2 (pt) sistema de liberação de fármaco oftálmico contendo fosfolipídio e colesterol.
DK2381988T3 (da) Medikamentadministrationsanordning
EP2023900A4 (en) DRUG DELIVERY SYSTEM WITH CONTROLLED DOSES
BRPI0908231A2 (pt) Sistema de liberação de fármaco com efeito estabilizante
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
EP2226083A4 (en) ACTIVE RELEASE SYSTEM
BRPI0821741A2 (pt) Sistema ii de liberação de droga
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations